摘要
目的探究右美托咪定对由脂多糖(lipopolysaccharide,LPS)诱发支气管上皮细胞活化及炎性反应的影响。方法人支气管上皮细胞系(human bronchial epithelial cell line,16HBE),经纯化鉴定后分为5组:正常对照组;LPS预处理组:将1μg/ml LPS预处理支气管上皮细胞24 h;右美托咪定低剂量组、右美托咪定中剂量组、右美托咪定高剂量组为支气管上皮细胞在1μg/ml LPS预处理24 h后分别加入5、10、20 ng/ml右美托咪定处理1 h。使用Western-blot检测c-Jun氨基末端激酶(c-Jun N-terminal kinase,JNK)和磷酸化c-Jun氨基末端激酶(phosphorylated c-Jun N-terminal kinases,p-JNK)的表达;使用逆转录-聚合酶链式反应(reverse transcription polymerase chain reaction,RT-PCR)法检测各组支气管上皮细胞培养基中的肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)mRNA,白细胞介素8(interleukin-8,IL-8)mRNA和白细胞介素1β(interleukin-1β,IL-1β)mRNA的表达水平;使用酶联免疫吸附试验(enzyme linked immunosorbent assay,ELISA)测定各组支气管上皮细胞培养上清液的IL-1β、IL-8和TNF-α浓度。结果与对照组比较,LPS预处理组IL-1βmRNA、IL-8 mRNA和TNF-αmRNA表达显著上调,培养基上清液中IL-8、TNF-α、IL-1β释放显著增加,p-JNK/JNK比率明显上调,差异具有统计学意义(P<0.05);与LPS预处理组比较,右美托咪定中剂量组、右美托咪定高剂量组p-JNK/JNK比率明显下调,IL-1βmRNA、IL-8 mRNA、TNF-αmRNA表达水平及IL-8、TNF-α、IL-1β浓度明显降低,组间比较差异具有统计学意义(P<0.05),而右美托咪定低剂量组上述指标与LPS预处理组比较差异均无统计学意义(P>0.05)。结论 10 ng/ml和20 ng/ml的右美托咪定可抑制LPS诱导的支气管上皮细胞炎症反应。
Objective To explore the effects of Dexmedetomidine on lipopolysaccharide(LPS)-induced inflammatory response of human bronchial epithelial cells(16 HBE).Methods The 16 HBE were collected and cultured invitro.After purificated and identificated,16 HBE were divided into five groups:control group,LPS group was pretreated with 1μg/ml LPS for 24 h,Dexmedetomidine low-,medium-and high-dose groups were all pretreated with LPS at 1μg/ml for24 h,and respectively added 5,10,20 ng/ml Dexmedetomidine for 1 h.The expressions of c-Jun N-terminal kinases(JNK)and phosphorylated c-Jun N-terminal kinases(p-JNK)were tested by Western blot.The expressions of tumor necrosis factor-α(TNF-α)mRNA,interleukin-8(IL-8)and interleukin-1β(IL-1β)mRNA were measured by reverse transcription polymerase chain reaction(RT-PCR)in bronchial epithelial cells of every group.The concentration of IL-8,IL-1βand TNF-αwere respectively measured by enzyme linked immunosorbent assay(ELISA).Results Compared with control group,the expressions of TNF-αmRNA,IL-1βand IL-8 mRNA in LPS group were significantly up-regulated,meanwhile,IL-8,TNF-α,IL-1β and the ratio of p-JNK/JNK in the supernatant from medium were all increased(P〈0.05).Compared with LPS group,the expressions and concentrations of forementioned inflammatory mediators were significantly inhibited and the ratio of p-JNK/JNK down-regulated in Dexmedetomidine medium-and high-dose groups(P〈0.05).No significant differences were found in above mediators between Dexmedetomidine low-dose group and LPS group(P〉0.05).Conclusion Dexmedetomidine at 10 ng/ml and 20 ng/ml can inhibit the LPS-induced inflammatory response of16 HBE.
作者
任娟
叶济世
胡振红
刘海潮
REN Juan;YE Jishi;HU Zhenhong;LIU Haichao(Department of Respiratory Medicine,Wuhan General Hospital of Chinese People's Liberation Army,Wuhan Hubei 430070,China)
出处
《华南国防医学杂志》
CAS
2018年第8期517-521,共5页
Military Medical Journal of South China
关键词
右美托咪定
支气管上皮细胞
脂多糖
炎症反应
Dexmedetomidine
Bronchial epithelial cell
Lipopolysaccharide
Inflammatory response